Literature DB >> 22789136

CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.

Robert J Plenter1, Todd J Grazia, An N Doan, Ronald G Gill, Biagio A Pietra.   

Abstract

BACKGROUND: Previous studies have shown that acute CD4 T-cell-mediated cardiac allograft rejection requires donor major histocompatibility complex (MHC) Class II expression and can be independent of "indirect" antigen presentation. However, other studies suggested that indirect antigen presentation to CD4 T cells may play a primary role in cellular xenograft immunity. Thus, the relative roles of direct/indirect CD4 T cell reactivity against cardiac xenografts are unclear. In this study we set out to determine the role for indirect CD4 T cell reactivity in cardiac xenograft rejection.
METHODS: Rat hearts were transplanted heterotopically into wild-type and immunodeficient mice. Recipients were untreated, treated with depleting antibodies, or reconstituted with wild-type cells.
RESULTS: Antibody depletion confirmed that rat heart xenograft rejection in C57Bl/6 mice was CD4 T-cell-dependent. Also, heart xenografts survived long term in B6 MHC Class II (C2D)-deficient mice. Graft acceptance in C2D mice was not secondary to CD4 T cell deficiency alone, because transferred B6 CD4 T cells failed to trigger rejection in C2D hosts. Furthermore, purified CD4 T cells were sufficient for acute rejection of rat heart xenografts in immune-deficient B6rag1(-/-) recipients. Importantly, CD4 T cells did not reject rat hearts in C2Drag1(-/-) hosts, in contrast to results using cardiac allografts. "Direct" xenoreactive CD4 T cells were not sufficient to mediate rejection despite vigorous reactivity to rat stimulator cells in vitro.
CONCLUSIONS: Taken together, our results show that CD4 T cells are both necessary and sufficient for acute cardiac xenograft rejection and that host MHC Class II is critical in this process.
Copyright © 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22789136      PMCID: PMC3418866          DOI: 10.1016/j.healun.2012.05.018

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  48 in total

1.  Dendritic cells require T cells for functional maturation in vivo.

Authors:  V Shreedhar; A M Moodycliffe; S E Ullrich; C Bucana; M L Kripke; L Flores-Romo
Journal:  Immunity       Date:  1999-11       Impact factor: 31.745

2.  CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.

Authors:  B A Pietra; A Wiseman; A Bolwerk; M Rizeq; R G Gill
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

3.  Langerhans cells that have matured in vivo in the absence of T cells are fully capable of inducing a helper CD4 as well as a cytotoxic CD8 response.

Authors:  A De Creus; K Van Beneden; T Taghon; F Stolz; V Debacker; J Plum; G Leclercq
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  CD4+ T cells initiate pancreatic islet xenograft rejection via an interferon-gamma-dependent recruitment of macrophages and natural killer cells.

Authors:  Shounan Yi; Ximin Feng; Wayne J Hawthorne; Anita T Patel; Stacey N Walters; Philip J O'Connell
Journal:  Transplantation       Date:  2002-02-15       Impact factor: 4.939

5.  Rituximab as monotherapy for elicited xenoreactive antibody responses.

Authors:  Gonzalo V Gonzalez-Stawinski; R Duane Davis
Journal:  J Heart Lung Transplant       Date:  2006-10-30       Impact factor: 10.247

Review 6.  Novel roles of complement in T effector cell regulation.

Authors:  Peter S Heeger; Claudia Kemper
Journal:  Immunobiology       Date:  2011-07-13       Impact factor: 3.144

7.  A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts.

Authors:  T Friedman; R N Smith; R B Colvin; J Iacomini
Journal:  Diabetes       Date:  1999-12       Impact factor: 9.461

8.  The critical role of mouse CD4+ cells in the rejection of highly disparate xenogeneic pig thymus grafts.

Authors:  Y Zhao; K Swenson; T Wekerle; J I Rodriguez-Barbosa; J S Arn; M Sykes
Journal:  Xenotransplantation       Date:  2000-05       Impact factor: 3.907

Review 9.  Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases.

Authors:  D K Cooper; A M Keogh; J Brink; P A Corris; W Klepetko; R N Pierson; M Schmoeckel; R Shirakura; L Warner Stevenson
Journal:  J Heart Lung Transplant       Date:  2000-12       Impact factor: 10.247

Review 10.  Pig-to-non-human primate heart transplantation: immunologic progress over 20 years.

Authors:  Xiaocheng Zhu; Frank J M F Dor; David K C Cooper
Journal:  J Heart Lung Transplant       Date:  2007-03       Impact factor: 10.247

View more
  4 in total

Review 1.  A Paradigm Shift on the Question of B Cells in Transplantation? Recent Insights on Regulating the Alloresponse.

Authors:  Daniel J Firl; Gilles Benichou; James I Kim; Heidi Yeh
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

2.  Leflunomide Inhibits rat-to-Mouse Cardiac Xenograft Rejection by Suppressing Adaptive Immune Cell Response and NF-κB Signaling Activation.

Authors:  Yunhan Ma; Baiyi Xie; Junjun Guo; Yingyu Chen; Mengya Zhong; Qingru Lin; Jianyu Hua; Jiaying Zhong; Xuewei Luo; Guoliang Yan; Helong Dai; Zhongquan Qi
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

3.  Deletion of Smad3 improves cardiac allograft rejection in mice.

Authors:  Ying-Ying Wang; Hong Jiang; Yu-Cheng Wang; Xiao-Ru Huang; Jun Pan; Chen Yang; Zhang-Fei Shou; Shi-Long Xiang; Da-Jin Chen; Hui-Yao Lan; Jiang-Hua Chen
Journal:  Oncotarget       Date:  2015-07-10

4.  Immunosuppressive effect of arsenic trioxide on islet xenotransplantation prolongs xenograft survival in mice.

Authors:  Bin Zhao; Jun-Jie Xia; Lu-Min Wang; Chang Gao; Jia-Li Li; Jia-Yin Liu; Qi-Jun Cheng; Chen Dai; Qi-Lin Ma; Zhong-Quan Qi; Ben-Hua Zhao
Journal:  Cell Death Dis       Date:  2018-03-14       Impact factor: 8.469

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.